Can Corneal Cross-Linking Be Used To Treat Myopia?

August 21, 2016

Earlier this year, Avedro, Inc. received approvals from the FDA to use Photrexa Viscous and Photrexa riboflavin solutions with its KXL System for corneal collagen cross-linking for the treatment of progressive keratoconus, and corneal ectasia following refractive surgery.

On August 16, 2016, Avedro announced a new clinical trial together with Toulouse University Hospital in France to evaluate the safety and efficacy of corneal cross linking for the treatment of myopia.

Click here to read more.




Jump down to form below to submit your own comments

Comments are closed.